Number of shares and voting rights of Innate Pharma as at July 17, 2019

NEXT STORY
Curetis to Present at Solebury Trout European Biotech Investor Day in NYC
PREV STORY
Roxadustat China Phase 3 Trial for Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine (NEJM)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sun BioPharma, Inc. Announces Dosing of First Patient in Phase 1 Clinical Study of SBP-101 for Pancreatic Cancer

 Developing a disruptive therapeutics platform targeting large unmet medical needs;First-in-class proprietary polyamine compound designed ...

author_avatar
NASDAQ Market News

INmune Bio Co-Founder and CEO RJ Tesi Presents at Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit

author_avatar
NASDAQ Market News

Castle Connolly Medical Ltd. Continues to Expand Its Database of Top Doctors Across the U.S.

New York, NY, May 15, 2018 (GLOBE NEWSWIRE) -- Castle Connolly Medical Ltd. (www.castleconnolly.com) ...

author_avatar
NASDAQ Market News